Stevens‐Johnson Syndrome Associated with Abacavir Therapy | Zendy

Philippe Bossi | Zendy; Jean Claude Roujeau | Zendy; François Bricaire | Zendy; Éric Caumes | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Stevens‐Johnson Syndrome Associated with Abacavir Therapy

Author(s) -

Philippe Bossi,

Jean Claude Roujeau,

François Bricaire,

Éric Caumes

Publication year - 2002

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/342571

Subject(s) - medicine , abacavir , antiretroviral therapy , virology , human immunodeficiency virus (hiv) , viral load

1. Levin AS, Barone AA, Penço J, et al. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumanii. Clin Infect Dis 1999; 28:1008–11. 2. Stein A, Bataille JF, Drancourt M, et al. Ambulatory treatment of multidrug-resistant Staphylococcus–infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole). Antimicrob Agents Chemother 1998; 42:3086–91. 3. Yow EM, Tan E, Shane L, Schonfeld S, AbuNassar H. Colistin (Colymycin) in resistant bacterial infections. Arch Intern Med 1961; 108: 64–70. 4. Cathpole CR, Andrews JM, Brenwald N, Wise R. A reassessment of the in-vitro activity of colistin sulphomethate sodium. J Antimicrob Chemother 1997; 39:255–60. 5. Kunin CM, Buggn A. Binding of polymycin antibiotics to tissues: the major determinant of distribution and persistence in the body. J Infect Dis 1971; 124:394–400.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research